PMID- 25615956 OWN - NLM STAT- MEDLINE DCOM- 20160121 LR - 20150403 IS - 1898-4002 (Electronic) IS - 1896-1126 (Linking) VI - 60 IP - 1 DP - 2015 Mar TI - No association between vitamin D levels and inflammation markers in patients with acute coronary syndrome. PG - 89-93 LID - S1896-1126(14)00101-1 [pii] LID - 10.1016/j.advms.2014.12.003 [doi] AB - PURPOSE: A modern concept regards acute coronary syndrome (ACS) as an auto-inflammatory disorder. The purpose of the present study is to assess the plasma levels of inflammation related to biomarkers and cytokines in ACS patients and to correlate the values with 25-hydroxy vitamin D3 (calcidiol). There are no previously published reports concerning serum concentrations of inflammatory markers in patients with hypovitaminosis D in ACS. PATIENTS AND METHODS: Eighty-eight consecutive patients with ACS [n=47 ST elevation myocardial infarction (STEMI), n=41 unstable angina pectoris (USAP)] were enrolled within 12h after symptoms. The blood samples were collected on admission in order to evaluate calcidiol, serum amyloid A (SAA), interleukin (IL)-6, interleukin (IL)-10, tumor necrosis factor-alpha (TNFalpha) and high sensitivity C-reactive protein (hsCRP). RESULTS: Calcidiol, TNFalpha and SAA levels were significantly lower (p=0.01, p<0.01 and p<0.01 respectively), whereas hsCRP levels were significantly higher (p<0.01) in STEMI group as compared to USAP group. In the STEMI group, there were negative correlations between SAA and hsCRP (r=-0.347; p=0.01) and SAA and IL-6 (r=-0.356; p=0.01). There was a positive correlation between IL-6 and hsCRP (r=0.529; p<0.01). In the USAP group, it was found that there were a strong negative correlation between SAA and hsCRP (r=-0.75; p<0.01) and a positive correlation between IL-6 and TNF-alpha (r=0.54; p<0.01). CONCLUSION: This study demonstrates that calcidiol levels are not associated with the inflammation markers in patients with acute phase ACS. CI - Copyright (c) 2014 Medical University of Bialystok. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved. FAU - Eren, Esin AU - Eren E AD - Antalya Public Health Center of Ministry of Health, Antalya, Turkey. Electronic address: esinerendr@gmail.com. FAU - Ellidag, Hamit Yasar AU - Ellidag HY AD - Central Laboratories of Antalya Education and Research Hospital of Ministry of Health, Antalya, Turkey. FAU - Yilmaz, Akar AU - Yilmaz A AD - Cardiology of Antalya Education and Research Hospital of Ministry of Health, Antalya, Turkey. FAU - Aydin, Ozgur AU - Aydin O AD - Central Laboratories of Antalya Education and Research Hospital of Ministry of Health, Antalya, Turkey. FAU - Yilmaz, Necat AU - Yilmaz N AD - Central Laboratories of Antalya Education and Research Hospital of Ministry of Health, Antalya, Turkey. LA - eng PT - Journal Article DEP - 20150103 PL - Netherlands TA - Adv Med Sci JT - Advances in medical sciences JID - 101276222 RN - 0 (Biomarkers) RN - 0 (IL10 protein, human) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) RN - 0 (Serum Amyloid A Protein) RN - 0 (TNF protein, human) RN - 0 (Tumor Necrosis Factor-alpha) RN - 130068-27-8 (Interleukin-10) RN - 1406-16-2 (Vitamin D) SB - IM MH - Acute Coronary Syndrome/*blood MH - Aged MH - Biomarkers/*blood MH - Female MH - Humans MH - Inflammation/*blood MH - Interleukin-10/blood MH - Interleukin-6/blood MH - Male MH - Middle Aged MH - Serum Amyloid A Protein/metabolism MH - Tumor Necrosis Factor-alpha/blood MH - Vitamin D/*blood OTO - NOTNLM OT - Acute coronary syndrome OT - Interleukin-10 OT - Interleukin-6 OT - Serum amyloid A OT - Vitamin D EDAT- 2015/01/24 06:00 MHDA- 2016/01/23 06:00 CRDT- 2015/01/24 06:00 PHST- 2014/05/08 00:00 [received] PHST- 2014/12/01 00:00 [revised] PHST- 2014/12/22 00:00 [accepted] PHST- 2015/01/24 06:00 [entrez] PHST- 2015/01/24 06:00 [pubmed] PHST- 2016/01/23 06:00 [medline] AID - S1896-1126(14)00101-1 [pii] AID - 10.1016/j.advms.2014.12.003 [doi] PST - ppublish SO - Adv Med Sci. 2015 Mar;60(1):89-93. doi: 10.1016/j.advms.2014.12.003. Epub 2015 Jan 3.